Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid, Acute

Explore clinical trials studying Leukemia, Myeloid, Acute. Study availability and eligibility vary by location and protocol.

2,461 public trials 543 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid, Acute trial results

Completed

Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

NCT03092674

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
View all 506 locations
View Trial Details
Completed

Study of FF-10101-01 in Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT03194685

Conditions
AML, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • University of California Los Angeles, David Geffen School of Medicine Los Angeles, California, United States
  • University Of California, San Francisco School of Medicine San Francisco, California, United States
  • Northwestern University Chicago, Illinois, United States
  • Johns Hopkins Hospital - Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details
Completed

A Phase Ib/II Multicenter Open-label Study of Bemcentinib (BGB324) in Patients With AML or MDS

NCT02488408

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States
  • Medizinische Hochschule Hannover,Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation, Hanover, Carl-Neuberg-Str, Germany
  • University Medical Center Hamburg Hamburg, Hamburg-Eppendorf, Germany
View Trial Details
Completed

Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT02085408

Conditions
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), +29 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Arizona Cancer Center at University Medical Center North Tucson, Arizona, United States
  • University of Arizona Health Sciences Center Tucson, Arizona, United States
View all 269 locations
View Trial Details
Completed

Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT02014558

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Site US10021 Birmingham, Alabama, United States
  • Site US10023 Scottsdale, Arizona, United States
  • Site US10022 Duarte, California, United States
  • Site US10008 Los Angeles, California, United States
View all 26 locations
View Trial Details
Completed

A Study of ASP2215 (Gilteritinib) Combined With Atezolizumab in Patients With Relapsed or Treatment Refractory FMS-like Tyrosine Kinase (FLT3) Mutated Acute Myeloid Leukemia (AML)

NCT03730012

Conditions
Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation, Hematologic Diseases, +6 more
Locations
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Kentucky Lexington, Kentucky, United States
View Trial Details

Related conditions